Epic Research, a branch of the electronic health record company Epic, is using its massive Cosmos database to conduct large-scale medical research studies. Instead of relying on the traditional journal route, … [Read More]
A recent study has shown that continuous glucose monitoring (CGM) may be a useful tool for patients undergoing dialysis for kidney disease—particularly those with diabetes—because it uncovers episodes of high … [Read More]
Walmart will become the first brick‑and‑mortar U.S. retailer to offer an over‑the‑counter continuous glucose monitor (CGM), the Lingo from Abbott Diabetes Care, in its physical stores and online.
What’s New
Previously available only via HelloLingo.com … [Read More]
A recent nationwide study in Denmark found that over half of adults without diabetes who started a GLP-1 RA drug (e.g., semaglutide, which is known by its trade name Wegovy) for weight loss discontinued the … [Read More]
A new tool combining continuous glucose monitoring (CGM) with artificial intelligence (AI) has been cleared by the U.S. Food and Drug Administration (FDA) to help adults manage their weight. The product, called the Signos Glucose Monitoring … [Read More]
Taurine is an amino sulfonic acid (not a protein-building amino acid) that naturally occurs in the body and is found in foods such as meat and fish. It’s also widely … [Read More]
U.S. Health Secretary Robert F. Kennedy Jr. announced on June 24, 2025, that the Department of Health and Human Services (HHS) will soon roll out a nationwide campaign to promote the use of … [Read More]
Smart Devices Help T2D Patients Spend More Time in Healthy Glucose Range
A new study from Denmark showed that using telemonitoring technology helped people with type 2 diabetes (T2D) manage their blood sugar better than standard care. … [Read More]
Researchers studied almost 90,000 middle-aged and older adults in the UK over a period of nearly 10 years. Everyone in the study wore a wrist device (an accelerometer) that tracked how … [Read More]
Some new breast cancer drugs, such as inavolisib, alpelisib, and capivasertib, can cause a serious side effect: hyperglycemia, (high blood sugar). These drugs block the PI3K/Akt pathway, which is … [Read More]